Breast Biopsy Devices Market will be Dominate in coming years 2020-2023 With Industry Analysis, Scope, COVID Report and Forecast Till 2023

Global breast biopsy market was valued at $977 million in 2016, and is projected to reach at $1,420 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. Core needle biopsy (CNB) segment accounted for about half of the global market share in 2016.

Request Sample Report at:https://www.alliedmarketresearch.com/request-sample/1067

The major factors that boost the market growth include rise in incidence of breast cancer, growth in awareness toward cancer screening programs, and increase in demand for minimal invasive breast biopsies. Moreover, the ongoing technological advancements of diagnostic and treatment technology for breast cancer have undergone a gradual transition from open surgery to minimal invasive biopsy procedures. Breast cancer is the most common type of cancer in women, especially in the U.S., where it is the second leading cause of death propels the demand for breast biopsy procedures. Furthermore, requirement of robust measures for disease control, the thrust for newer technologies has led to the development of minimal invasive surgeries. This has made breast biopsy as preferred modality to diagnose breast cancer and identify complex tumors and make accurate diagnosis. However, lack of awareness toward the availability of novel breast biopsy techniques and risk of infection involved in the procedures are projected to hamper the market growth.

Key Findings of the Breast Biopsy Market:

In 2016, core needle biopsy (CNB) led the overall breast biopsy market revenue, and is projected to grow at a CAGR of 5.6% during the forecast period.
The mammography guided stereotactic biopsy segment occupied the highest share among image guided technology in 2016, and is expected to grow at a CAGR of 5.6%.
In 2016, North America generated highest revenue, region-wise, with over three-sevenths share of the global market.
The number of breast biopsy procedures is growing at a CAGR of 4.2% from 2017 to 2023.
The ultrasound guided biopsy segment is expected to witness the highest growth rate from 2017 to 2023.
Get detailed COVID-19 impact analysis on the Breast Biopsy Market: https://www.alliedmarketresearch.com/request-for-customization/1067?reqfor=covid

Key players operating in the market include

Hologic Inc.
Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.)
C. R. Bard, Inc.
Becton and Dickinson Company
Argon Medical Devices
Cook Medical Incorporated
Encapsule medical Devices LLC.
Ethicon Endo Surgery (Johnson & Johnson)
Intact Medical Corporation
Galini SRL
The core needle biopsy (CNB) segment dominated the global market in 2016, and is expected to maintain this trend throughout the analysis period, owing to the less invasive procedure compared to others and it provides more definitive diagnosis. Moreover, use of CNB and ultra sonographic and mammographic guidance is highly accurate for diagnosing breast cancer that supplements the market growth.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/1067

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.